Lexaria receives USD million Australian tax rebate cash payment
Lexaria Bioscience Corp. says it has received a cash tax rebate payment related to its 2025 Australian human study results.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.